Anna Kowalczyk
Impact in
-
- Antibiotic Use and Resistance
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Antibiotic Use and Resistance 8
-
- Patient Satisfaction in Healthcare 9
- Health Policy Implementation Science 4
- Co-authors
- Maciek Godycki-ĆwirkoDavid L. ScottFowzia IbrahimMichel WensingPeter J. MaddisonGabrielle KingsleyD. MulherinAidan G. O’Keeffe
- Journals
- BMJ Open (4 papers)Implementation Science (3 papers)Trials (3 papers)PLoS ONE (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- PolandNetherlandsUnited Kingdom
In The Last Decade
Anna Kowalczyk
48 papers receiving 894 citations
Peers
Comparison fields: 5 of 128
- Applied Microbiology and Biotechnology 75
- Rheumatology 269
- Molecular Medicine 86
- Hematology 135
- Immunology 191
Countries citing papers authored by Anna Kowalczyk
This map shows the geographic impact of Anna Kowalczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kowalczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kowalczyk more than expected).
Fields of papers citing papers by Anna Kowalczyk
This network shows the impact of papers produced by Anna Kowalczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kowalczyk. The network helps show where Anna Kowalczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Kowalczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 0 | |
| 8 | 2021 | 6 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 2 | |
| 11 | 2018 | 7 | |
| 12 | 2017 | 24 | |
| 13 | 2014 | 103 | |
| 14 | 2014 | 46 | |
| 15 | 2013 | 12 | |
| 16 | 2013 | 8 | |
| 17 | 2012 | 233 | |
| 18 | One Year Randomised Controlled Trial of SEcond Line Agents in Myositis (SELAM): Late Additional immunosuppression is Ineffective in Patients Who Have Partially Responded to Steroids | 2011 | 2 |
| 19 | 2011 | 9 | |
| 20 | 2003 | 1 |
About Anna Kowalczyk
Anna Kowalczyk is a scholar working on Applied Microbiology and Biotechnology, General Health Professions, Health Informatics, Epidemiology and Urology, having authored 54 papers that have together received 911 indexed citations. Recurring topics across this work include Urinary Tract Infections Management (14 papers), Patient Satisfaction in Healthcare (9 papers), Antibiotic Use and Resistance (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Chronic Disease Management Strategies (4 papers), Pelvic floor disorders treatments (4 papers), Urinary Bladder and Prostate Research (4 papers) and Health Policy Implementation Science (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (75 citations), Rheumatology (269 citations), Molecular Medicine (86 citations), Hematology (135 citations) and Immunology (191 citations). Anna Kowalczyk has collaborated with scholars based in Poland, Netherlands and United Kingdom. Frequent co-authors include Maciek Godycki-Ćwirko, David L. Scott, Fowzia Ibrahim, Michel Wensing, Peter J. Maddison, Gabrielle Kingsley, D. Mulherin, Aidan G. O’Keeffe, Neil McHugh and Jon Packham. Their work appears in journals such as BMJ Open, Implementation Science, Trials, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.